Clinical Development of Biological Response Modifiers
OBJECTIVE: To present perspectives on selected issues that frequently arise during the clinical development of biological response modifier (BRM) therapies.
Saved in:
Main Author: | Jay P Siegel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1994-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1994/583805 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of biologic response modifiers for the management of ocular inflammatory conditions
by: Erick Rivera-Grana, et al.
Published: (2018-01-01) -
Biological Response Modifiers in Combination with Antivirals against Experimentally-Induced Virus Infections
by: Robert W Sidwell, et al.
Published: (1992-01-01) -
Treatment of HIV-1 Infection with Combination Therapy: Antiretroviral Agents and Biological Response Modifiers
by: Steven M Schnittman
Published: (1994-01-01) -
Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine
by: Claire I. Daïen, et al.
Published: (2014-01-01) -
Application of Chemically Modified and Unmodified Waste Biological Sorbents in Treatment of Wastewater
by: John Kanayochukwu Nduka
Published: (2012-01-01)